Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of apararenone in diabetic nephropathy
NCT02676401Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apararenone in diabetic nephropathy (DN), sponsored by Mitsubishi Tanabe Pharma Corporation. Started Feb 2016; status: completed.
02
Drugs
apararenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02676401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676401.